"Emerging Environmental Issues" Workshop Planning Meeting
Monday, May 6, 2002
4-5 PM, CIIT Conference Room 121
The following people attended the meeting: Paul Schlosser, Greg Blumenthal, Rob DeWoskin Woody Setzer, Jeff Hayward, Jane Staveley, and Shawn Sager.
Agenda
Comment from Jonathon Wiener: Interesting questions about the USGS report on pharmaceutical residuals include: whether the FDA ever considered where the pharmaceuticals would end up after human consumption (or USDA for animal drugs), if not why not, whether Life Cycle Analysis or other methods of risk analysis could be applied to improve such decision-making, and to what extent accounting for the environmental risks of pharmaceutical residuals would make a difference in the agency's decision-making. It's a classic example of a risk-risk tradeoff.
Discussion
Potential topics and speakers:
Removal from drinking water - USEPA Cincinnati
Pharmaceutical companies - FDA doesn't look at it. There is an environmental assessment related to registration.
Christian Doughton - overview; USEPA Las Vegas
Policy overview
Integrated Risk Guidelines - Linda Tischler, NCEA Cincinnati
Aquaculture - FDA Center for Veterinary Medicine
Groundwater results - USGS; released in July
Measurements - effects of drugs on animals, e.g., bovine growth hormone
Therapeutic animal dose - residual levels in water (USDA)
Tolerance levels - how are they established, etc.
Sponsorship: USGS, FDA, USDA, USEPA, Carolina SETAC
Location: Toxicology building, Centennial Campus
Seats about 100 people in the auditorium
Use lobby for refreshments
Next Meeting: June 3, 2002; lunch - 11:30 AM to 1:00 PM